Global Hepatitis A Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 96

Published Date: 09 May 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Hepatitis A Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hepatitis A Vaccine market size is estimated to be worth US$ 726.3 million in 2021 and is forecast to a readjusted size of USD 842.5 million by 2028 with a CAGR of 2.1% during forecast period 2022-2028. Government Institution accounting for % of the Hepatitis A Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Vaccine segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, and Zhejiang Pukang, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Hepatitis A Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Inactivated Vaccine
    Live Attenuated Vaccine

Market segment by Application can be divided into
    Government Institution
    Private Sector
    Other

The key market players for global Hepatitis A Vaccine market are listed below:
    GSK
    Merck
    Sanofi
    Sinovac
    Zhejiang Pukang
    Changchun Institute of Biological
    KM Biologics
    IMBCAMS
    Convac

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis A Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis A Vaccine, with price, sales, revenue and global market share of Hepatitis A Vaccine from 2019 to 2022.
Chapter 3, the Hepatitis A Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hepatitis A Vaccine.
Chapter 13, 14, and 15, to describe Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Hepatitis A Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Hepatitis A Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Inactivated Vaccine
        1.2.3 Live Attenuated Vaccine
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Hepatitis A Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Global Hepatitis A Vaccine Market Size & Forecast
        1.4.1 Global Hepatitis A Vaccine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Hepatitis A Vaccine Sales in Volume (2017-2028)
        1.4.3 Global Hepatitis A Vaccine Price (2017-2028)
    1.5 Global Hepatitis A Vaccine Production Capacity Analysis
        1.5.1 Global Hepatitis A Vaccine Total Production Capacity (2017-2028)
        1.5.2 Global Hepatitis A Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Hepatitis A Vaccine Market Drivers
        1.6.2 Hepatitis A Vaccine Market Restraints
        1.6.3 Hepatitis A Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Hepatitis A Vaccine Product and Services
        2.1.4 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Hepatitis A Vaccine Product and Services
        2.2.4 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Sanofi
        2.3.1 Sanofi Details
        2.3.2 Sanofi Major Business
        2.3.3 Sanofi Hepatitis A Vaccine Product and Services
        2.3.4 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Sinovac
        2.4.1 Sinovac Details
        2.4.2 Sinovac Major Business
        2.4.3 Sinovac Hepatitis A Vaccine Product and Services
        2.4.4 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Zhejiang Pukang
        2.5.1 Zhejiang Pukang Details
        2.5.2 Zhejiang Pukang Major Business
        2.5.3 Zhejiang Pukang Hepatitis A Vaccine Product and Services
        2.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Changchun Institute of Biological
        2.6.1 Changchun Institute of Biological Details
        2.6.2 Changchun Institute of Biological Major Business
        2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Product and Services
        2.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 KM Biologics
        2.7.1 KM Biologics Details
        2.7.2 KM Biologics Major Business
        2.7.3 KM Biologics Hepatitis A Vaccine Product and Services
        2.7.4 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 IMBCAMS
        2.8.1 IMBCAMS Details
        2.8.2 IMBCAMS Major Business
        2.8.3 IMBCAMS Hepatitis A Vaccine Product and Services
        2.8.4 IMBCAMS Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Convac
        2.9.1 Convac Details
        2.9.2 Convac Major Business
        2.9.3 Convac Hepatitis A Vaccine Product and Services
        2.9.4 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Hepatitis A Vaccine Breakdown Data by Manufacturer
    3.1 Global Hepatitis A Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Hepatitis A Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Hepatitis A Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2021
        3.4.2 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2021
    3.5 Global Hepatitis A Vaccine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Hepatitis A Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Hepatitis A Vaccine Market Size by Region
        4.1.1 Global Hepatitis A Vaccine Sales in Volume by Region (2017-2028)
        4.1.2 Global Hepatitis A Vaccine Revenue by Region (2017-2028)
    4.2 North America Hepatitis A Vaccine Revenue (2017-2028)
    4.3 Europe Hepatitis A Vaccine Revenue (2017-2028)
    4.4 Asia-Pacific Hepatitis A Vaccine Revenue (2017-2028)
    4.5 South America Hepatitis A Vaccine Revenue (2017-2028)
    4.6 Middle East and Africa Hepatitis A Vaccine Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Hepatitis A Vaccine Sales in Volume by Type (2017-2028)
    5.2 Global Hepatitis A Vaccine Revenue by Type (2017-2028)
    5.3 Global Hepatitis A Vaccine Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Hepatitis A Vaccine Sales in Volume by Application (2017-2028)
    6.2 Global Hepatitis A Vaccine Revenue by Application (2017-2028)
    6.3 Global Hepatitis A Vaccine Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Hepatitis A Vaccine Sales by Type (2017-2028)
    7.2 North America Hepatitis A Vaccine Sales by Application (2017-2028)
    7.3 North America Hepatitis A Vaccine Market Size by Country
        7.3.1 North America Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        7.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028)
    8.2 Europe Hepatitis A Vaccine Sales by Application (2017-2028)
    8.3 Europe Hepatitis A Vaccine Market Size by Country
        8.3.1 Europe Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Hepatitis A Vaccine Sales by Type (2017-2028)
    9.2 Asia-Pacific Hepatitis A Vaccine Sales by Application (2017-2028)
    9.3 Asia-Pacific Hepatitis A Vaccine Market Size by Region
        9.3.1 Asia-Pacific Hepatitis A Vaccine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Hepatitis A Vaccine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Hepatitis A Vaccine Sales by Type (2017-2028)
    10.2 South America Hepatitis A Vaccine Sales by Application (2017-2028)
    10.3 South America Hepatitis A Vaccine Market Size by Country
        10.3.1 South America Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        10.3.2 South America Hepatitis A Vaccine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Hepatitis A Vaccine Sales by Type (2017-2028)
    11.2 Middle East & Africa Hepatitis A Vaccine Sales by Application (2017-2028)
    11.3 Middle East & Africa Hepatitis A Vaccine Market Size by Country
        11.3.1 Middle East & Africa Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Hepatitis A Vaccine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Hepatitis A Vaccine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Hepatitis A Vaccine
    12.3 Hepatitis A Vaccine Production Process
    12.4 Hepatitis A Vaccine Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Hepatitis A Vaccine Typical Distributors
    13.3 Hepatitis A Vaccine Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Hepatitis A Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Hepatitis A Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. GSK Basic Information, Manufacturing Base and Competitors
    Table 4. GSK Major Business
    Table 5. GSK Hepatitis A Vaccine Product and Services
    Table 6. GSK Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Merck Basic Information, Manufacturing Base and Competitors
    Table 8. Merck Major Business
    Table 9. Merck Hepatitis A Vaccine Product and Services
    Table 10. Merck Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 12. Sanofi Major Business
    Table 13. Sanofi Hepatitis A Vaccine Product and Services
    Table 14. Sanofi Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 16. Sinovac Major Business
    Table 17. Sinovac Hepatitis A Vaccine Product and Services
    Table 18. Sinovac Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Zhejiang Pukang Basic Information, Manufacturing Base and Competitors
    Table 20. Zhejiang Pukang Major Business
    Table 21. Zhejiang Pukang Hepatitis A Vaccine Product and Services
    Table 22. Zhejiang Pukang Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 24. Changchun Institute of Biological Major Business
    Table 25. Changchun Institute of Biological Hepatitis A Vaccine Product and Services
    Table 26. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 28. KM Biologics Major Business
    Table 29. KM Biologics Hepatitis A Vaccine Product and Services
    Table 30. KM Biologics Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. IMBCAMS Basic Information, Manufacturing Base and Competitors
    Table 32. IMBCAMS Major Business
    Table 33. IMBCAMS Hepatitis A Vaccine Product and Services
    Table 34. IMBCAMS Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Convac Basic Information, Manufacturing Base and Competitors
    Table 36. Convac Major Business
    Table 37. Convac Hepatitis A Vaccine Product and Services
    Table 38. Convac Hepatitis A Vaccine Sales (K Unit), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Global Hepatitis A Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Unit)
    Table 40. Global Hepatitis A Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 41. Market Position of Manufacturers in Hepatitis A Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 42. Global Hepatitis A Vaccine Production Capacity by Company, (K Unit): 2020 VS 2021
    Table 43. Head Office and Hepatitis A Vaccine Production Site of Key Manufacturer
    Table 44. Hepatitis A Vaccine New Entrant and Capacity Expansion Plans
    Table 45. Hepatitis A Vaccine Mergers & Acquisitions in the Past Five Years
    Table 46. Global Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
    Table 47. Global Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
    Table 48. Global Hepatitis A Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 49. Global Hepatitis A Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 50. Global Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 51. Global Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 52. Global Hepatitis A Vaccine Revenue by Type (2017-2022) & (USD Million)
    Table 53. Global Hepatitis A Vaccine Revenue by Type (2023-2028) & (USD Million)
    Table 54. Global Hepatitis A Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 55. Global Hepatitis A Vaccine Price by Type (2023-2028) & (USD/Unit)
    Table 56. Global Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 57. Global Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 58. Global Hepatitis A Vaccine Revenue by Application (2017-2022) & (USD Million)
    Table 59. Global Hepatitis A Vaccine Revenue by Application (2023-2028) & (USD Million)
    Table 60. Global Hepatitis A Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 61. Global Hepatitis A Vaccine Price by Application (2023-2028) & (USD/Unit)
    Table 62. North America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
    Table 63. North America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
    Table 64. North America Hepatitis A Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 65. North America Hepatitis A Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 66. North America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 67. North America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 68. North America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 69. North America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 70. Europe Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
    Table 71. Europe Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
    Table 72. Europe Hepatitis A Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 73. Europe Hepatitis A Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 74. Europe Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 75. Europe Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 76. Europe Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 77. Europe Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 78. Asia-Pacific Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
    Table 79. Asia-Pacific Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
    Table 80. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 81. Asia-Pacific Hepatitis A Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 82. Asia-Pacific Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 83. Asia-Pacific Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 84. Asia-Pacific Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 85. Asia-Pacific Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 86. South America Hepatitis A Vaccine Sales by Country (2017-2022) & (K Unit)
    Table 87. South America Hepatitis A Vaccine Sales by Country (2023-2028) & (K Unit)
    Table 88. South America Hepatitis A Vaccine Revenue by Country (2017-2022) & (USD Million)
    Table 89. South America Hepatitis A Vaccine Revenue by Country (2023-2028) & (USD Million)
    Table 90. South America Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 91. South America Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 92. South America Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 93. South America Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 94. Middle East & Africa Hepatitis A Vaccine Sales by Region (2017-2022) & (K Unit)
    Table 95. Middle East & Africa Hepatitis A Vaccine Sales by Region (2023-2028) & (K Unit)
    Table 96. Middle East & Africa Hepatitis A Vaccine Revenue by Region (2017-2022) & (USD Million)
    Table 97. Middle East & Africa Hepatitis A Vaccine Revenue by Region (2023-2028) & (USD Million)
    Table 98. Middle East & Africa Hepatitis A Vaccine Sales by Type (2017-2022) & (K Unit)
    Table 99. Middle East & Africa Hepatitis A Vaccine Sales by Type (2023-2028) & (K Unit)
    Table 100. Middle East & Africa Hepatitis A Vaccine Sales by Application (2017-2022) & (K Unit)
    Table 101. Middle East & Africa Hepatitis A Vaccine Sales by Application (2023-2028) & (K Unit)
    Table 102. Hepatitis A Vaccine Raw Material
    Table 103. Key Manufacturers of Hepatitis A Vaccine Raw Materials
    Table 104. Direct Channel Pros & Cons
    Table 105. Indirect Channel Pros & Cons
    Table 106. Hepatitis A Vaccine Typical Distributors
    Table 107. Hepatitis A Vaccine Typical Customers
List of Figures
    Figure 1. Hepatitis A Vaccine Picture
    Figure 2. Global Hepatitis A Vaccine Revenue Market Share by Type in 2021
    Figure 3. Inactivated Vaccine
    Figure 4. Live Attenuated Vaccine
    Figure 5. Global Hepatitis A Vaccine Revenue Market Share by Application in 2021
    Figure 6. Government Institution
    Figure 7. Private Sector
    Figure 8. Other
    Figure 9. Global Hepatitis A Vaccine Revenue, (USD Million) & (K Unit): 2017 & 2021 & 2028
    Figure 10. Global Hepatitis A Vaccine Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Hepatitis A Vaccine Sales (2017-2028) & (K Unit)
    Figure 12. Global Hepatitis A Vaccine Price (2017-2028) & (USD/Unit)
    Figure 13. Global Hepatitis A Vaccine Production Capacity (2017-2028) & (K Unit)
    Figure 14. Global Hepatitis A Vaccine Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Hepatitis A Vaccine Market Drivers
    Figure 16. Hepatitis A Vaccine Market Restraints
    Figure 17. Hepatitis A Vaccine Market Trends
    Figure 18. Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2021
    Figure 19. Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2021
    Figure 20. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
    Figure 24. Global Hepatitis A Vaccine Revenue Market Share by Region (2017-2028)
    Figure 25. North America Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
    Figure 28. South America Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Hepatitis A Vaccine Revenue (2017-2028) & (USD Million)
    Figure 30. Global Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 31. Global Hepatitis A Vaccine Revenue Market Share by Type (2017-2028)
    Figure 32. Global Hepatitis A Vaccine Price by Type (2017-2028) & (USD/Unit)
    Figure 33. Global Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 34. Global Hepatitis A Vaccine Revenue Market Share by Application (2017-2028)
    Figure 35. Global Hepatitis A Vaccine Price by Application (2017-2028) & (USD/Unit)
    Figure 36. North America Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 37. North America Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 38. North America Hepatitis A Vaccine Sales Market Share by Country (2017-2028)
    Figure 39. North America Hepatitis A Vaccine Revenue Market Share by Country (2017-2028)
    Figure 40. United States Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 44. Europe Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 45. Europe Hepatitis A Vaccine Sales Market Share by Country (2017-2028)
    Figure 46. Europe Hepatitis A Vaccine Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Hepatitis A Vaccine Revenue Market Share by Region (2017-2028)
    Figure 56. China Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 63. South America Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 64. South America Hepatitis A Vaccine Sales Market Share by Country (2017-2028)
    Figure 65. South America Hepatitis A Vaccine Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Hepatitis A Vaccine Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Hepatitis A Vaccine Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Hepatitis A Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Hepatitis A Vaccine in 2021
    Figure 77. Manufacturing Process Analysis of Hepatitis A Vaccine
    Figure 78. Hepatitis A Vaccine Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac

Related Reports

Global Hepatitis A Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Hepatitis A Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 05 Jun 2021

date Pharma & Healthcare

The Hepatitis A Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Hepatitis A Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Hepatitis A Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period.

Global Hepatitis A Vaccine Supply, Demand and Key Producers, 2024-2030

Global Hepatitis A Vaccine Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

The global Hepatitis A Vaccine market size is expected to reach $ 842.5 million by 2030, rising at a market growth of 2.1% CAGR during the forecast period (2024-2030).

Product Tags

hepatitis a vaccine

mono hepatitis a vaccine

Inactivated Hepatitis A Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>